Discussion on the Correlation between miRNA and the Regulatory Mechanism of Hepatocellular Carcinoma Cells

Authors

  • Yutong Ma

DOI:

https://doi.org/10.61173/me2r3h18

Keywords:

-microRNA, hepatocellular carcinoma, pro-liferation, migration, invasion

Abstract

Hepatocellular carcinoma, ranking as the sixth most prevalent malignant neoplasm globally, is characterized by a propensity for rapid proliferation and a high tendency to metastasize to distant sites within the body. microRNAs control the expression of liver cancer cells by targeting specific mRNA sequences. At present, miRNAs have made a lot of progress in the early detection and continuous tracking of liver cancer cells, as well as in creating ways to diagnose liver cancer using blood samples. However, there is still a big gap in the research on using miRNAs for the prompt identification and intervention for hepatic carcinoma. To identify unique effects resulting from miRNAs on how liver cancer is regulated, this study looked at the regulatory mechanisms of miRNAs and paid special attention to specific miRNAs like miR-590-5p. Outcomes demonstrated approach could modulate growth dynamics, migratory behavior, metastatic potential among cancerous hepatic cells, hence participating in the early diagnosis of liver cancer. This study aims to summarize and analyze the regulatory pathways of miRNAs in liver cancer, Aiming to contribute pertinent knowledge to the exploration of the early-stage diagnosis and treatment for malignant hepatic tumors.

References

[1] K. O. Asafo-Agyei and H. Samant, “Hepatocellular Carcinoma,” in StatPearls [Internet], Treasure Island, FL: StatPearls Publishing, 2025.

[2] P. T. B. Ho, I. M. Clark, and L. T. T. Le, “MicroRNA-Based Diagnosis and Therapy,” International Journal of Molecular Sciences, vol. 23, no. 13, p. 7167, 2022.

[3] B. M. Hussen, S. T. Abdullah, M. F. Rasul, et al., “MicroRNAs: important players in breast cancer angiogenesis Dean&Francis ISSN 2959-409X and therapeutic targets,” Frontiers in Molecular Biosciences, vol. 8, p. 764025, 2021.

[4] T. S. Barwal, N. Singh, U. Sharma, et al., “miR-590-5p: A double-edged sword in the oncogenesis process,” Cancer Treatment and Research Communications, vol. 32, p. 100593, 2022.

[5] R. Wei, X. Zhang, X. Wang, et al., “PDCD4 restricts PRRSV replication in an eIF4A-dependent manner and is antagonized by the viral nonstructural protein 9,” Journal of Virology, vol. 98, no. 5, e0006024, 2024.

[6] S. Mm Yahya and G. H. Elsayed, “The role of MiRNA-34 family in different signaling pathways and its therapeutic options,” Gene, vol. 931, p. 148829, 2024.

[7] Y. Zhang, Q. Yan, Y. Chen, et al., “Effect of miRNA- 34a targeting Bcl-2 on the growth and migration ability of hepatocellular carcinoma HepG2 cells,” Western Medical Journal, vol. 34, no. 11, pp. 1613–1616+1623, 2022.

[8] S. S. Youssef, A. Elfiky, M. M. Nabeel, et al., “Assessment of circulating levels of microRNA-326, microRNA-424, and microRNA-511 as biomarkers for hepatocellular carcinoma in Egyptians,” World Journal of Hepatology, vol. 14, no. 8, pp. 1562–1575, 2022.

[9] J. Sun, “miR-424-5p affects the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the expression of CLDN6,” Master’s thesis, Jilin University, 2023.

[10] Y. Wen, J. Han, J. Chen, et al., “Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma,” International Journal of Cancer, vol. 137, no. 7, pp. 1679–1690, 2015.

[11] W. Feng, C. Bai, X. Li, et al., “Research progress on the application of miRNAs in the diagnosis of hepatocellular carcinoma,” Journal of Chifeng University (Natural Science Edition), vol. 40, no. 08, pp. 18–21, 2024.

[12] T. Tadokoro, A. Morishita, and T. Masaki, “Diagnosis and Therapeutic Management of Liver Fibrosis by MicroRNA,” International Journal of Molecular Sciences, vol. 22, no. 15, p. 8139, 2021.

Downloads

Published

2025-08-26